Is targeted biologic therapy transforming management approaches for severe uncontrolled asthma?
Managing severe asthma requires advanced therapeutic strategies beyond standard high-dose inhaled corticosteroids. Detailed analysis within the Severe Asthma Treatment Market report outlines how monoclonal antibodies targeting specific inflammatory cytokines—such as IL-4, IL-5, and IgE—are improving clinical outcomes. These biologic agents reduce severe exacerbations and lower...
0 Comments 0 Shares 172 Views 0 Reviews